Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Microcap & Penny Stocks : The Microcap Kitchen: Stocks 5¢ to $5 -- Ignore unavailable to you. Want to Upgrade?

To: GARY P GROBBEL who wrote (72783)	3/14/2008 1:08:46 PM
From: GARY P GROBBEL	Read Replies (1) \| Respond to of 120414

SYMBA .80...see PR ref the China play earlier this week. The guy who put together and is running that company in China that will now become a SYMBA subs used to work for SYMBA here in the states and was instrumental in putting together many of the company current products. The synergies here are extensive and the ability to market SYMBA products into China could really work out well for the company. They know and trust this guy....and they can now get data for 20 cents on the buck as opposed to costs here in the US. Just spoke to them and the Phase 3 results are due by end of this month. You can't find a drug/bio with Phase 3 results due in a couple weeks at this absurd price....shows what kind of mkt we are in. 3mo chart- bigcharts.marketwatch.com